Ποια είναι η τιμή για Zhejiang Jolly Pharmaceutical Co.,LTD (300181)

Η τιμή για Zhejiang Jolly Pharmaceutical Co.,LTD (300181) είναι $2.00

Ποια είναι η κεφαλαιοποίηση αγοράς για Zhejiang Jolly Pharmaceutical Co.,LTD (300181)

Η κεφαλαιοποίηση αγοράς για Zhejiang Jolly Pharmaceutical Co.,LTD (300181) είναι $1.39B

Zhejiang Jolly Pharmaceutical Co.,LTD (300181) Τιμή και Κεφαλαιοποίηση Αγοράς

Zhejiang Jolly Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the research, manufacturing, and global distribution of traditional Chinese medicinal products. The company's diverse portfolio includes the Wuling capsule, prescribed for conditions such as insomnia, amnesia, heart palpitations, general fatigue, weakness in the lower back and legs, and tinnitus. This capsule also addresses energy deficiency and a weak pulse often linked to an imbalance of the heart and kidneys, or neurasthenia. Additionally, they produce the Lingze tablet, which targets frequent or painful urination, weak or continuous urine flow, and lower back and knee soreness, especially when these symptoms are associated with benign prostatic hyperplasia, kidney insufficiency, or blood stasis. Another offering, the Bailing tablet, serves as an adjunctive treatment for coughs, asthma, back pain, and chronic bronchitis stemming from lung and kidney deficiencies. The firm also markets Linglianhua particles, used to manage symptoms including excessive sweating, sleep disturbances, irritability, heart flutters, vivid dreams, dizziness with tinnitus, lower back and leg weakness, dry stools, an unusual tongue appearance, and a feeble pulse, often seen in perimenopausal syndrome or heart and kidney disharmony. Beyond these traditional Chinese medicine formulations, Zhejiang Jolly Pharmaceutical provides a range of injectable pharmaceuticals, such as azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside. The company further supplies raw medicinal ingredients, including cordyceps cephalosporium, fermented cordyceps, and Wuling powders. Expanding its reach into healthcare services, Zhejiang Jolly Pharmaceutical Co., Ltd. invests in and participates with Deqing No.3 People's Hospital. Established in 2000 and based in Huzhou, China, the entity now known as Zhejiang Jolly Pharmaceutical Co., Ltd. adopted this name in 1998, evolving from its earlier designation, Zhejiang Jolly Pharmaceutical Health Products Co., LTD.

Η τιμή για 300181	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$7,593.39 $1.39B	NVDA	$5.264T	+378,781.69%
$6,781.82 $1.39B	AAPL	$4.701T	+338,287.56%
$6,025.79 $1.39B	GOOG	$4.177T	+300,564.12%
$5,506.79 $1.39B	MSFT	$3.817T	+274,668.19%
$4,134.83 $1.39B	AMZN	$2.866T	+206,212.66%

Η τιμή για 300181

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$7,593.39 $1.39B